The GDPR (General Data Protection Regulation) includes provisions that support the secondary use of existing health data for scientific research purposes, while also protecting the privacy and data protection rights of individuals.
One of the key ways that the GDPR supports the secondary use of health data for research is through the concept of “legitimate interests”. Article 6(1)(f) of the GDPR allows for the processing of personal data if it is necessary for the legitimate interests of the data controller or a third party, provided that those interests do not override the fundamental rights and freedoms of the data subject. Scientific research can be considered a legitimate interest, provided that appropriate safeguards are in place to protect individuals’ rights and freedoms.
In addition, the GDPR includes provisions that specifically address the use of health data for scientific research. For example, Article 9(2)(j) allows for the processing of special categories of personal data, such as health data, for scientific research purposes, provided that appropriate safeguards are in place.
The GDPR also requires that data controllers implement appropriate technical and organizational measures to ensure the security and confidentiality of personal data, including health data. This includes requirements for data pseudonymization and encryption, as well as procedures for data breach notification.
Overall, the GDPR strikes a balance between protecting individuals’ privacy and data protection rights, and supporting the important public interest in scientific research. By providing a framework for the responsible and transparent use of health data for research purposes, the GDPR can help to facilitate the development of new treatments and interventions that can improve public health outcomes.
Share this story...
RWE 101 – The Evolution of Real World Evidence Regulations
RWE 101 - The Evolution of Real World Evidence Regulations Real-world evidence (RWE) has become an increasingly important source of data for regulatory decision-making in healthcare. The [...]
RWE 101 – Is Real World Evidence a Replacement for Clinical Trials?
RWE 101 - Is Real World Evidence a Replacement for Clinical Trials? Real world evidence (RWE) is not a replacement for clinical trials. Clinical trials are considered [...]
RWE 101 – How Robust is RWE?
RWE 101 - How Robust is RWE? Real world evidence (RWE) is evidence that is collected outside of traditional randomized controlled trials (RCTs), such as observational studies [...]
RWE 101 – What is the Connection between Real World Data (RWD) and Real World Evidence (RWE)?
RWE 101 - 4 Potential Uses for Improving Drug Development Real world data (RWD) refers to any data that is generated outside of a clinical trial setting, [...]
RWE 101 – The Role of RWE in the Context of Digital Health
RWE 101 - The Role of RWE in the Context of Digital Health Digital health refers to the use of digital technologies, such as mobile devices, wearables, [...]
RWE 101 – Purpose of Real World Evidence
RWE 101 - Purpose of Real World Evidence The purpose of real-world evidence (RWE) is to provide insights into the safety, effectiveness, and value of medical products [...]







